GNI Group Ltd. logo

GNI Group Ltd.

TSE:2160.T

Overview | Financials
Company Name GNI Group Ltd.
Symbol 2160.T
Currency JPY
Price 2,095
Market Cap 104,875,017,030
Dividend Yield 0%
52-week-range 1,537 - 3,865
Industry Biotechnology
Sector Healthcare
CEO Dr. Ying Luo Ph.D.
Website https://www.gnipharma.com

An error occurred while fetching data.

About GNI Group Ltd.

GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs and traditional Chinese medicines in Japan and internationally. It provides Etuary for the treatment of idiopathic pulmonary fibrosis. The company is also developing Etuary, which is in Phase III clinical trial for the treatment of connective

Related Stocks

SanBio Company Limited logo

SanBio Company Limited

4592.T

938 JPY

AnGes, Inc. logo

AnGes, Inc.

4563.T

54 JPY

CellSource Co., Ltd. logo

CellSource Co., Ltd.

4880.T

1,416 JPY

Eiken Chemical Co., Ltd. logo

Eiken Chemical Co., Ltd.

4549.T

2,326 JPY

Pharma Foods International Co., Ltd. logo

Pharma Foods International Co., Ltd.

2929.T

955 JPY

Elan Corporation logo

Elan Corporation

6099.T

812 JPY

Genky DrugStores Co., Ltd. logo

Genky DrugStores Co., Ltd.

9267.T

3,680 JPY

CYBERDYNE Inc. logo

CYBERDYNE Inc.

7779.T

203 JPY

MedPeer,Inc. logo

MedPeer,Inc.

6095.T

610 JPY

Cawachi Limited logo

Cawachi Limited

2664.T

2,673 JPY

Financials

Numbers are in millions USD

Numbers are in millions USD